Ischaemic heart disease

Antiplatelets compared in PCI: one stands out in Australian study

A study comparing P2Y12 inhibitors in Australian patients undergoing PCI has found that prasugrel in combination with aspirin was associated with better two-year outcomes compared to ticagrelor and clopidogrel. Prasugrel had significantly lower rates of the composite outcome of death, myocardial infarction and stroke at one and two years after PCI compared to other P2Y12 ...

Already a member?

Login to keep reading.

© 2021 the limbic